Pegfilgrastim biosimilar (Bio-Ker)

培非格司亭生物类似药 (Bio-Ker)

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePegfilgrastim biosimilar (Bio-Ker)

Drug Alias NameG-CSF/PEG 20K非格司亭生物仿制药 (Bio-Ker)培非司亭生物仿制药 (Bio-Ker)培非拉司亭生物仿制药 (Bio-Ker)培非格司亭生物仿制药 (Bio-Ker)

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar

Mechanisms of ActionHaematopoiesis stimulantsColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesBio-Ker Srl

China Registration ClassN/A

Active CompaniesBio-Ker Srl

Inactive CompaniesN/A

Active IndicationsNeutropenia

Inactive IndicationsN/A

ATC CodeL03AA13